miR-184, which is modulated by programmed cell death 4 (PDCD4), directly targets BCL2 and C-MYC and participates in PDCD4-mediated suppression of cell proliferation and survival in NPC [56]. This evidence concerns the gene BCL2 and nasopharyngeal carcinoma.